Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJohnson Matthey Regulatory News (JMAT)

Share Price Information for Johnson Matthey (JMAT)

Share Price is delayed by 15 minutes
Get Live Data
1,980.00    0.00 (0.00%)
Bid:
0.00
Ask:
2,500.00
Spread: 528.00 (26.775%)
Market Cap: £3.32b
JMAT Live PriceLast checked at - London Stock Exchange

Intraday Johnson Matthey Share Chart

Directorate Change

9 Sep 2024 07:00

RNS Number : 3088D
Johnson Matthey PLC
09 September 2024
 

9th September 2024

 

Johnson Matthey Plc

(the Company)

Sinead Lynch to join Johnson Matthey as a Non-Executive Director

 

The Company is pleased to announce the appointment of Sinead Lynch as an independent Non-Executive Director with effect from 1st January 2025. Sinead will also become a member of the Remuneration, Nomination and Societal Value Committees.

 

Sinead brings a deep understanding of low carbon energy and sustainability, having spent 30 years in the energy sector at Royal Dutch Shell ("Shell") and BG Group ("BG"), including the last 10 years in an executive capacity. Most recently, she led Shell's Low Carbon Fuels business, developing technologies and investing in projects to produce sustainable renewable fuels at scale. Prior to this, Sinead was the UK Country Chair at Shell and led the Safety and Sustainability division of BG before its acquisition by Shell. She was also co-chair of the UK Hydrogen Advisory Council from 1st July 2020 until 1st August 2021.

 

Following a seven-year tenure, Jane Griffiths has taken the decision to step down as Chair of the Societal Value Committee and from the Board on 31st December 2024. Rita Forst will succeed Jane as Chair of the Societal Value Committee from 1st January 2025.

 

 

 

Patrick Thomas, Chair of Johnson Matthey said:

 

"On behalf of the Board, I would like to thank Jane for her significant contributions during her time with Johnson Matthey. In particular, her input and challenge to our sustainability commitments has been invaluable, and I wish her well for the future. I'm very pleased to welcome Sinead to the Board and look forward to benefiting from her expertise and advice, as JM continues to transform into an industry-leading energy transition company."

 

 

There are no further matters to be disclosed pursuant to UK Listing Rule 6.4.8R

 

 

ENDS

 

Enquiries: 

 

Simon Price

General Counsel and Company Secretary

+44 20 7269 8052

Martin Dunwoodie

Director of Investor Relations

+44 20 7269 8241

 

Johnson Matthey Plc is listed on the London Stock Exchange (JMAT)

Registered in England & Wales number: 00033774Legal Entity Identifier number: 2138001AVBSD1HSC6Z10

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAGZGGLVVRGDZM
Date   Source Headline
9th Aug 20211:52 pmRNSDirector/PDMR Shareholding
6th Aug 202111:45 amRNSHolding(s) in Company
5th Aug 20212:47 pmRNSDirector/PDMR Shareholding
5th Aug 202112:17 pmRNSDirector/PDMR Shareholding
5th Aug 202112:13 pmRNSDirector/PDMR Shareholding
5th Aug 202112:06 pmRNSDirector/PDMR Shareholding
5th Aug 202111:43 amRNSDirector/PDMR Shareholding
4th Aug 20214:22 pmRNSDirector/PDMR Shareholding
4th Aug 20214:08 pmRNSDirector/PDMR Shareholding
4th Aug 20213:51 pmRNSDirector/PDMR Shareholding
4th Aug 20213:34 pmRNSDirector/PDMR Shareholding
2nd Aug 20213:45 pmRNSHolding(s) in Company
30th Jul 20214:15 pmRNSHolding(s) in Company
29th Jul 202112:40 pmRNSResult of AGM
29th Jul 20217:00 amRNSDirectorate Change
29th Jul 20217:00 amRNSJohnson Matthey Q1 AGM trading update
22nd Jul 20214:24 pmRNSDirector/PDMR Shareholding
13th Jul 20215:39 pmRNSHolding(s) in Company
12th Jul 20214:05 pmRNSHolding(s) in Company
9th Jul 20215:01 pmRNSHolding(s) in Company
21st Jun 20213:15 pmRNSHolding(s) in Company
18th Jun 20213:54 pmRNSHolding(s) in Company
17th Jun 20213:56 pmRNSDirector/PDMR Shareholding
15th Jun 20219:00 amRNSAnnual Financial Report
10th Jun 20214:15 pmRNSHolding(s) in Company
27th May 20217:04 amRNSPreliminary results for year ended 31st March 2021
26th May 20217:00 amRNSJohnson Matthey and Plug Power green hydrogen MoU
20th May 202111:34 amRNSDirector/PDMR Shareholding
23rd Apr 20219:51 amRNSDirector/PDMR Shareholding
19th Apr 20217:00 amRNSStrategic developments in eLNO commercialisation
9th Apr 20214:10 pmRNSHolding(s) in Company
8th Apr 202111:10 amRNSHolding(s) in Company
8th Apr 20217:00 amRNSTrading update and strategic review of Health
24th Mar 202111:14 amRNSHolding(s) in Company
19th Mar 20213:00 pmRNSHolding(s) in Company
18th Mar 202111:53 amRNSDirector/PDMR Shareholding
9th Mar 20214:40 pmRNSHolding(s) in Company
8th Mar 202112:20 pmRNSHolding(s) in Company
24th Feb 20214:17 pmRNSDirector/PDMR Shareholding
18th Feb 20213:45 pmRNSDirector/PDMR Shareholding
16th Feb 20219:15 amRNSHolding(s) in Company
12th Feb 202110:15 amRNSHolding(s) in Company
8th Feb 20212:14 pmRNSDirector/PDMR Shareholding
8th Feb 20212:02 pmRNSDirector/PDMR Shareholding
22nd Jan 20214:15 pmRNSHolding(s) in Company
22nd Jan 202110:31 amRNSDirector/PDMR Shareholding
12th Jan 20217:00 amRNSAppointment of Chief Financial Officer
18th Dec 20203:29 pmRNSDirector/PDMR Shareholding
20th Nov 20202:55 pmRNSDirector/PDMR Shareholding
19th Nov 20207:00 amRNSJohnson Matthey half year results 30 Sept 2020

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.